tiprankstipranks
Lincoln Pharmaceuticals Ltd (IN:LINCOLN)
:LINCOLN
India Market
LINCOLN
Lincoln Pharmaceuticals Ltd
RESEARCH TOOLSreports

Lincoln Pharmaceuticals Ltd (LINCOLN) Ratios

2 Followers

Lincoln Pharmaceuticals Ltd Ratios

IN:LINCOLN's free cash flow for Q2 2026 was ₹0.32. For the 2026 fiscal year, IN:LINCOLN's free cash flow was decreased by ₹ and operating cash flow was ₹0.18. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 4.71 4.71 4.84 5.09 3.90
Quick Ratio
 4.01 3.97 4.01 4.12 3.10
Cash Ratio
 0.20 0.13 0.06 0.07 0.08
Solvency Ratio
 0.73 0.76 0.97 0.97 0.76
Operating Cash Flow Ratio
 0.43 0.88 0.69 0.54 0.84
Short-Term Operating Cash Flow Coverage
 744.96 0.00 59.26 19.66 37.25
Net Current Asset Value
₹ 4.07B₹ 3.75B₹ 3.39B₹ 2.82B₹ 2.51B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 0.00 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 0.00 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 0.00 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.19 1.19 1.18 1.17 1.23
Debt Service Coverage Ratio
 74.93 51.59 41.63 20.88 22.57
Interest Coverage Ratio
 77.35 47.05 56.81 38.42 113.69
Debt to Market Cap
 <0.01 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.59 0.94 1.26 2.01 1.74
Net Debt to EBITDA
 -0.20 -0.11 -0.03 -0.03 -0.05
Profitability Margins
Gross Profit Margin
43.16%53.26%51.24%51.33%52.60%
EBIT Margin
15.51%17.82%21.22%20.22%20.80%
EBITDA Margin
17.67%19.89%23.14%22.12%22.53%
Operating Profit Margin
13.12%14.22%14.33%15.45%35.24%
Pretax Profit Margin
17.67%17.52%21.06%19.90%20.49%
Net Profit Margin
13.47%13.21%16.07%14.44%14.81%
Continuous Operations Profit Margin
13.47%13.21%16.07%14.44%14.81%
Net Income Per EBT
76.27%75.42%76.33%72.55%72.29%
EBT Per EBIT
134.69%123.25%146.89%128.83%58.15%
Return on Assets (ROA)
10.28%10.33%13.32%12.41%12.98%
Return on Equity (ROE)
13.02%12.26%15.74%14.51%16.02%
Return on Capital Employed (ROCE)
11.58%12.83%13.69%15.14%37.17%
Return on Invested Capital (ROIC)
8.83%9.67%10.43%10.94%26.75%
Return on Tangible Assets
10.28%10.34%13.33%12.42%12.99%
Earnings Yield
7.59%7.44%7.79%10.73%11.15%
Efficiency Ratios
Receivables Turnover
 3.07 3.09 2.83 3.11 3.09
Payables Turnover
 4.19 3.43 3.91 4.80 4.36
Inventory Turnover
 4.58 3.70 3.67 3.51 3.05
Fixed Asset Turnover
 3.48 3.35 3.18 3.19 3.11
Asset Turnover
 0.76 0.78 0.83 0.86 0.88
Working Capital Turnover Ratio
 3.03 1.67 1.79 1.81 1.89
Cash Conversion Cycle
 111.22 110.27 135.27 145.48 153.95
Days of Sales Outstanding
 118.76 118.12 129.18 117.45 117.97
Days of Inventory Outstanding
 79.61 98.58 99.50 104.01 119.64
Days of Payables Outstanding
 87.15 106.43 93.40 75.98 83.66
Operating Cycle
 198.38 216.70 228.68 221.46 237.61
Cash Flow Ratios
Operating Cash Flow Per Share
 24.84 46.44 31.56 19.60 38.01
Free Cash Flow Per Share
 19.47 36.83 11.85 12.47 15.28
CapEx Per Share
 5.37 9.61 19.71 7.13 22.73
Free Cash Flow to Operating Cash Flow
 0.78 0.79 0.38 0.64 0.40
Dividend Paid and CapEx Coverage Ratio
 4.49 4.07 1.49 2.27 1.57
Capital Expenditure Coverage Ratio
 4.62 4.83 1.60 2.75 1.67
Operating Cash Flow Coverage Ratio
 744.96 0.00 59.26 19.66 37.25
Operating Cash Flow to Sales Ratio
 0.08 0.15 0.11 0.08 0.16
Free Cash Flow Yield
3.37%6.67%1.98%3.68%4.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 13.18 13.43 12.84 9.32 8.97
Price-to-Sales (P/S) Ratio
 1.78 1.77 2.06 1.35 1.33
Price-to-Book (P/B) Ratio
 1.62 1.65 2.02 1.35 1.44
Price-to-Free Cash Flow (P/FCF) Ratio
 29.69 14.99 50.45 27.20 20.33
Price-to-Operating Cash Flow Ratio
 23.27 11.89 18.95 17.31 8.17
Price-to-Earnings Growth (PEG) Ratio
 1.35 -1.14 0.46 1.82 0.79
Price-to-Fair Value
 1.62 1.65 2.02 1.35 1.44
Enterprise Value Multiple
 9.85 8.81 8.88 6.06 5.85
Enterprise Value
 11.35B 10.93B 11.93B 6.76B 6.17B
EV to EBITDA
 9.85 8.81 8.88 6.06 5.85
EV to Sales
 1.74 1.75 2.06 1.34 1.32
EV to Free Cash Flow
 29.10 14.81 50.25 27.08 20.17
EV to Operating Cash Flow
 22.81 11.75 18.87 17.23 8.11
Tangible Book Value Per Share
 357.12 335.10 295.79 250.72 215.93
Shareholders’ Equity Per Share
 357.35 335.31 295.96 250.86 216.12
Tax and Other Ratios
Effective Tax Rate
 0.24 0.25 0.24 0.27 0.28
Revenue Per Share
 325.48 311.13 289.82 252.10 233.75
Net Income Per Share
 43.85 41.11 46.58 36.40 34.63
Tax Burden
 0.76 0.75 0.76 0.73 0.72
Interest Burden
 1.14 0.98 0.99 0.98 0.99
Research & Development to Revenue
 0.00 0.02 0.00 0.00 0.00
SG&A to Revenue
 0.10 0.18 0.18 0.04 0.04
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.46 0.85 0.68 0.39 0.79
Currency in INR